@trevorjudd's testosterone therapy warning, fact-checked

What does this video actually claim?

Trevor Judd's Instagram video tells viewers to "run far far away" from something testosterone-related and "do your own research." The video doesn't specify what exactly to avoid, but given his TRT-focused hashtags and content history, he appears to be warning against conventional testosterone replacement therapy approaches or perhaps specific TRT practices.

Without seeing the actual video content, we're left to infer from his caption and hashtag strategy. He's positioning himself as someone questioning mainstream TRT guidance while promoting independent research.

Is "do your own research" good advice for TRT?

This phrase has become a red flag in medical contexts, and for good reason. TRT requires careful medical supervision because testosterone affects cardiovascular health, fertility, and prostate function in ways most people can't evaluate on their own.

The TTrials (Testosterone Trials) published in NEJM between 2016-2017 showed that while testosterone gel improved sexual function and mood in some older men with low testosterone, it also raised concerns about cardiovascular events. These studies involved careful monitoring of hematocrit levels, prostate-specific antigen, and cardiovascular markers.

Self-directed "research" typically means reading forums and influencer content, not peer-reviewed studies. Most men can't interpret lab values or recognize early signs of polycythemia, a potentially serious side effect where testosterone therapy increases red blood cell production to dangerous levels.

What's the actual evidence on TRT safety?

The data on TRT is genuinely mixed, which makes Judd's dramatic warning tone somewhat understandable but his solution problematic. The TRAVERSE trial (Lincoff et al., NEJM, 2023) followed 5,246 men for a median of 33 months and found no increased cardiovascular risk with testosterone gel compared to placebo.

However, earlier observational studies suggested increased heart attack and stroke risk. The FDA added cardiovascular warnings to testosterone products in 2015 based on this conflicting evidence.

Real TRT monitoring involves checking hematocrit every 3-6 months (target below 54%), PSA levels, and lipid panels. These aren't things you can "research" your way out of needing.

Where do TRT influencers often go wrong?

Many TRT content creators, possibly including Judd based on his approach here, frame this as a simple good-versus-evil narrative. They often promote "optimization" protocols using higher doses than FDA-approved TRT, sometimes combined with other hormones.

The Endocrine Society's 2018 testosterone therapy guidelines recommend doses that achieve testosterone levels in the mid-normal range (400-700 ng/dL), not the supraphysiologic levels some influencers promote. Higher isn't automatically better for cardiovascular and prostate risks.

Judd's "run away" advice might refer to legitimate concerns about overprescription or poor monitoring by some clinics. But his solution of independent research skips the important step of finding qualified medical supervision.

What should men actually know about TRT decisions?

The choice about TRT should involve a doctor who understands both the benefits and risks, not social media personalities or self-directed internet research. Two morning testosterone measurements below 300 ng/dL, combined with symptoms like low energy or decreased libido, might warrant TRT consideration.

But symptoms like fatigue have many causes. Sleep disorders, depression, and metabolic issues can all mimic low testosterone symptoms and might improve with different treatments.

If you're considering TRT, find an endocrinologist or urologist experienced with hormone therapy, not an anti-aging clinic that profits from selling testosterone. The medical supervision Judd seems to warn against is exactly what makes TRT safer when it's actually needed.